Correlation Engine 2.0
Clear Search sequence regions

  • bextra (2)
  • dynastat (1)
  • dysmenorrhea (2)
  • female (1)
  • humans (1)
  • isoform (1)
  • nsaids (1)
  • pain (1)
  • parecoxib (1)
  • prodrug (3)
  • rheumatoid arthritis (2)
  • tablets (1)
  • treatment pain (1)
  • valdecoxib (5)
  • Sizes of these terms reflect their relevance to your search.

    Valdecoxib (Bextra tablets of 10 mg and 20 mg) is a new non steroidal antiinflammatory drug (NSAID) that selectively inhibits COX-2 isoform of cyclo-oxygenase. It is indicated for the symptomatic treatment of osteoarthritis or rheumatoid arthritis (10 to 20 mg once a day) and for the treatment of primary dysmenorrhea (40 mg once a day). Valdecoxib is as efficacious as conventional non-COX-2 selective NSAIDs, but offers the advantage of a much better gastrointestinal tolerance. Valdecoxib has a prodrug that can be administered intravenously or intramuscularly (parecoxib, Dynastat) and has been developed for the short-term treatment of postsurgical pain.


    A J Scheen, M Malaise. Valdecoxib (Bextra)]. Revue médicale de Liège. 2004 Apr;59(4):251-4

    Expand section icon Mesh Tags

    Expand section icon Substances

    PMID: 15182039

    View Full Text